---
type: "Bill"
title: "AN ACT TO AMEND TITLE 24 OF THE DELAWARE CODE RELATING TO PRACTICE OF PHARMACY."
description: "All human laboratory testing is regulated under the Clinical Laboratory Improvement Amendments of 1988 (“CLIA”). CLIA-waived tests are simple laboratory examinations and procedures that have an insignificant risk of an erroneous result. Common CLIA-waived tests include Influenza, HIV, COVID-19, and lipid-panel tests. Amid COVID-19 pandemic, the need for immediate diagnostic services that are close to home became vital. This bill authorizes pharmacists to order and perform tests authorized by the FDA and CLIA-waived and provide treatment for such health conditions."
jurisdiction: "us/states/de"
legislature: "Delaware General Assembly"
session: "151"
identifier: "HB 399"
citation: "Delaware HB 399 (151)"
classification: ["bill"]
subjects: []
status: "enacted"
primary_sponsors: ["Andria L. Bennett", "Kendra Johnson", "Marie Pinkney"]
version_count: 4
action_count: 16
vote_count: 3
first_action: "2022-05-03"
last_action: "2022-10-03"
source: "openstates"
source_identifier: "ocd-bill/614f4e60-ae0f-42de-9e2e-a9a0e61e4bd0"
source_url: "https://legis.delaware.gov/BillDetail?LegislationId=109428"
source_hash: "2db59daa6dca240f12c542529a65c49ec0b08fa67dfd58a30b14e5b8c176bf1c"
vintage: "2026-07-01"
source_snapshot: "https://data.openstates.org/daily/2026-07-01/public.pgdump"
retrieved_at: "2026-07-06"
confidence: "reported"
tags: ["legislation", "bill", "us-de"]
---

# Delaware HB 399 (151) — AN ACT TO AMEND TITLE 24 OF THE DELAWARE CODE RELATING TO PRACTICE OF PHARMACY.

All human laboratory testing is regulated under the Clinical Laboratory Improvement Amendments of 1988 (“CLIA”). CLIA-waived tests are simple laboratory examinations and procedures that have an insignificant risk of an erroneous result. Common CLIA-waived tests include Influenza, HIV, COVID-19, and lipid-panel tests. Amid COVID-19 pandemic, the need for immediate diagnostic services that are close to home became vital. This bill authorizes pharmacists to order and perform tests authorized by the FDA and CLIA-waived and provide treatment for such health conditions.

## Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

1. **Bill Text** (committee substitute) — [source](https://legis.delaware.gov/json/BillDetail/GenerateHtmlDocument?legislationId=109428&legislationTypeId=1&docTypeId=2&legislationName=HB399)
2. **HA 1 to HB 399** (committee substitute) — [source](http://legis.delaware.gov/json/BillDetail/GeneratePdfDocument?legislationId=109532&legislationTypeId=5&docTypeId=2)
3. **HA 2 to HB 399** (committee substitute) — [source](http://legis.delaware.gov/json/BillDetail/GeneratePdfDocument?legislationId=109553&legislationTypeId=5&docTypeId=2)
4. **SA 1 to HB 399** (committee substitute) — [source](http://legis.delaware.gov/json/BillDetail/GeneratePdfDocument?legislationId=129886&legislationTypeId=5&docTypeId=2)

## Votes

- SM — **41–0** (pass) · lower
- SM — **39–0** (pass) · lower
- SM — **21–0** (pass) · upper

## Sponsors

- Andria L. Bennett — primary (person)
- Kendra Johnson — primary (person)
- Marie Pinkney — primary (person)
- Edward S. Osienski — cosponsor (person)
- Eric Morrison — cosponsor (person)
- Kimberly Williams — cosponsor (person)
- Paul S. Baumbach — cosponsor (person)
- Sherry Dorsey Walker — cosponsor (person)
- Spiros Mantzavinos — cosponsor (person)

## Timeline

The legislative action history — every referral, reading, and vote.

- **2022-05-03** Introduced and Assigned to Health & Human Development Committee in House `introduction, referral-committee`
- **2022-05-11** Reported Out of Committee (Health & Human Development) in House with 1 Favorable, 7 On Its Merits `committee-passage, committee-passage-favorable`
- **2022-05-17** Amendment HA 1 to HB 399 - Introduced and Placed With Bill `amendment-introduction`
- **2022-05-19** Amendment HA 2 to HB 399 - Introduced and Placed With Bill `amendment-introduction`
- **2022-05-19** Amendment HA 1 to HB 399 - Passed In House by Voice Vote `amendment-passage`
- **2022-05-19** Amendment HA 2 to HB 399 - Passed In House by Voice Vote `amendment-passage`
- **2022-05-19** Passed By House. Votes: 39 YES 2 ABSENT `passage`
- **2022-05-19** Assigned to Health & Social Services Committee in Senate `introduction, referral-committee`
- **2022-06-08** Reported Out of Committee (Health & Social Services) in Senate with 2 Favorable, 2 On Its Merits `committee-passage, committee-passage-favorable`
- **2022-06-30** Amendment SA 1 to HB 399 - Introduced and Placed With Bill `amendment-introduction`
- **2022-06-30** Amendment SA 1 to HB 399 - Passed By Senate. Votes: 21 YES `amendment-passage`
- **2022-06-30** Laid On Table in Senate
- **2022-07-01** Lifted From Table in Senate
- **2022-07-01** Passed By Senate. Votes: 21 YES `passage`
- **2022-07-01** Passed By House. Votes: 41 YES `passage`
- **2022-10-03** Signed by Governor `executive-signature`

## Source

OpenStates / OpenCivicData bulk snapshot [2026-07-01](https://data.openstates.org/daily/2026-07-01/public.pgdump); origin `ocd-bill/614f4e60-ae0f-42de-9e2e-a9a0e61e4bd0`. Confidence: reported (aggregated from official Delaware legislature records).